Stage III Non-Small Cell Lung Cancer

CONDITION

Cancer

GENDER

Both males and females

AGE GROUP

From 18

and above

STATUS

Terminated

This study for patients with Stage III non-small cell lung cancer seeks to assess whether the addition of oral veliparib versus placebo to Paclitaxel/Carboplatin-based chemoradiotherapy with Paclitaxel/Carboplatin consolidation will improve progression-free survival.

CONTACT DETAILS

Clinical Trial Site: Affinity Oncology
Phone Number: (08) 9446 8726 Email: info@affinityresearch.com.au Location: 55/85 Monash Avenue, Nedlands, Western Australia, Australia
  • Hidden

Approved By: Hollywood Private Hospital Research Ethics Committee              

Clinical Trial Registry Link: